Evidence map›Paper›PMID 33923148›Full record

ArticleMolecules (Basel, Switzerland)2021

Polyphenolic Profile of

Shahenda Mahgoub, Nashwa Hashad, Sahar Ali, Reham Ibrahim, Ahmed M Said, Fatma A Moharram, Mohamed Mady

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. RSC advances · 2024
    Article
  8. UHPLC-MS profiles and antidiarrheal activity ofFrontiers in pharmacology · 2023
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Shahenda MahgoubBiochemistry and Molecular Biology Department, Faculty of Pharmacy, Helwan University, Ein-Helwan, Helwan, Cairo 11795, Egypt.
Nashwa HashadDepartment of Pharmacognosy, Faculty of Pharmacy, Helwan University, Ein Helwan, Cairo 11795, Egypt.
Sahar AliBiochemistry and Molecular Biology Department, Faculty of Pharmacy, Helwan University, Ein-Helwan, Helwan, Cairo 11795, Egypt.
Reham IbrahimDepartment of Pharmacognosy, Faculty of Pharmacy, Helwan University, Ein Helwan, Cairo 11795, Egypt.
Ahmed M SaidDepartment of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Helwan University, Ein-Helwan, Helwan, Cairo 11795, Egypt.
Fatma A MoharramDepartment of Pharmacognosy, Faculty of Pharmacy, Helwan University, Ein Helwan, Cairo 11795, Egypt.
Mohamed MadyDepartment of Pharmacognosy, Faculty of Pharmacy, Helwan University, Ein Helwan, Cairo 11795, Egypt.ORCID 0000-0002-8754-0442
Helwan University · EGUniversity at Buffalo, State University of New York · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Five new compounds

Indexed as

Antineoplastic AgentsAntioxidantsArachidonate 5-LipoxygenaseHumansMCF-7 CellsMyrtaceaeOxidative StressPlant Components, AerialPolyphenolsALOX5 protein, humanAntineoplastic AgentsAntioxidantsArachidonate 5-LipoxygenasePolyphenols5-LOXantioxidantC. viminaliscytotoxicityflavonoidsmolecular modellingpolyphenolic

Identifiers

PMID33923148
PMCPMC8123052
OpenAlexW3159534366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.